1-17 of 17
Markku Saraheimo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Physical Activity Reduces Risk of Premature Mortality in Patients With Type 1 Diabetes With and Without Kidney Disease

Heidi Tikkanen-Dolenc, Johan Wadén, Carol Forsblom, Valma Harjutsalo, Lena M. Thorn, Markku Saraheimo, Nina Elonen, Heikki O. Tikkanen, Per-Henrik Groop
Journal: Diabetes Care
Diabetes Care 2017;40(12):1727–1732
https://doi.org/10.2337/dc17-0615
Published: 16 October 2017
View article titled, Physical Activity Reduces Risk of Premature Mortality in Patients With Type 1 Diabetes With and Without Kidney Disease
Open the PDF for Physical Activity Reduces Risk of Premature Mortality in Patients With Type 1 Diabetes With and Without Kidney Disease in another window
Includes: Supplementary data
Journal Articles

The Presence and Consequence of Nonalbuminuric Chronic Kidney Disease in Patients With Type 1 Diabetes

Lena M. Thorn, Daniel Gordin, Valma Harjutsalo, Stefanie Hägg, Robert Masar, Markku Saraheimo, Nina Tolonen, Johan Wadén, Per-Henrik Groop, Carol M. Forsblom
Journal: Diabetes Care
Diabetes Care 2015;38(11):2128–2133
https://doi.org/10.2337/dc15-0641
Published: 26 August 2015
View article titled, The Presence and Consequence of Nonalbuminuric Chronic Kidney Disease in Patients With Type 1 Diabetes
Open the PDF for The Presence and Consequence of Nonalbuminuric Chronic Kidney Disease in Patients With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Kidney Injury Molecule-1 and the Loss of Kidney Function in Diabetic Nephropathy: A Likely Causal Link in Patients With Type 1 Diabetes

Nicolae M. Panduru, Niina Sandholm, Carol Forsblom, Markku Saraheimo, Emma H. Dahlström, Lena M. Thorn, Daniel Gordin, Nina Tolonen, Johan Wadén, Valma Harjutsalo, Angelika Bierhaus, Per M. Humpert, Per-Henrik Groop
Journal: Diabetes Care
Diabetes Care 2015;38(6):1130–1137
https://doi.org/10.2337/dc14-2330
Published: 17 March 2015
View article titled, Kidney Injury Molecule-1 and the Loss of Kidney Function in Diabetic Nephropathy: A Likely Causal Link in Patients With Type 1 Diabetes
Open the PDF for Kidney Injury Molecule-1 and the Loss of Kidney Function in Diabetic Nephropathy: A Likely Causal Link in Patients With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Urinary Adiponectin Is an Independent Predictor of Progression to End-Stage Renal Disease in Patients With Type 1 Diabetes and Diabetic Nephropathy

Nicolae M. Panduru, Markku Saraheimo, Carol Forsblom, Lena M. Thorn, Daniel Gordin, Johan Wadén, Nina Tolonen, Angelika Bierhaus, Per M. Humpert, Per-Henrik Groop
Journal: Diabetes Care
Diabetes Care 2015;38(5):883–890
https://doi.org/10.2337/dc14-2276
Published: 26 February 2015
View article titled, Urinary Adiponectin Is an Independent Predictor of Progression to End-Stage Renal Disease in Patients With Type 1 Diabetes and Diabetic Nephropathy
Open the PDF for Urinary Adiponectin Is an Independent Predictor of Progression to End-Stage Renal Disease in Patients With Type 1 Diabetes and Diabetic Nephropathy in another window
Includes: Supplementary data
Journal Articles

Added Value of Soluble Tumor Necrosis Factor-α Receptor 1 as a Biomarker of ESRD Risk in Patients With Type 1 Diabetes

Carol Forsblom, John Moran, Valma Harjutsalo, Tony Loughman, Johan Wadén, Nina Tolonen, Lena Thorn, Markku Saraheimo, Daniel Gordin, Per-Henrik Groop, Merlin C. Thomas
Journal: Diabetes Care
Diabetes Care 2014;37(8):2334–2342
https://doi.org/10.2337/dc14-0225
Published: 12 July 2014
View article titled, Added Value of Soluble Tumor Necrosis Factor-α Receptor 1 as a Biomarker of ESRD Risk in Patients With Type 1 Diabetes
Open the PDF for Added Value of Soluble Tumor Necrosis Factor-α Receptor 1 as a Biomarker of ESRD Risk in Patients With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Antihypertensive Treatment and Resistant Hypertension in Patients With Type 1 Diabetes by Stages of Diabetic Nephropathy

Raija Lithovius, Valma Harjutsalo, Carol Forsblom, Markku Saraheimo, Per-Henrik Groop, on behalf of the FinnDiane Study Group
Journal: Diabetes Care
Diabetes Care 2014;37(3):709–717
https://doi.org/10.2337/dc13-2023
Published: 11 February 2014
View article titled, Antihypertensive Treatment and Resistant Hypertension in Patients With Type 1 Diabetes by Stages of Diabetic Nephropathy
Open the PDF for Antihypertensive Treatment and Resistant Hypertension in Patients With Type 1 Diabetes by Stages of Diabetic Nephropathy in another window
Includes: Supplementary data
Journal Articles

Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes

Daniel Gordin, MD, Aino Soro-Paavonen, MD, Merlin C. Thomas, MBCHB, Valma Harjutsalo, PHD, Markku Saraheimo, MD, Mette Bjerre, PHD, Carol Forsblom, DMSC, Allan Flyvbjerg, MD, Per-Henrik Groop, MD, on behalf of the FinnDiane Study Group
Journal: Diabetes Care
Diabetes Care 2013;36(7):1827–1833
https://doi.org/10.2337/dc12-2170
Published: 12 June 2013
View article titled, Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes
Open the PDF for Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes in another window
Journal Articles

Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes

Nicolae M. Panduru, MD, Carol Forsblom, DMSC, Markku Saraheimo, MD, Lena Thorn, MD, Angelika Bierhaus, PHD, Per M. Humpert, PHD, Per-Henrik Groop, MD, on behalf of the FinnDiane Study Group
Journal: Diabetes Care
Diabetes Care 2013;36(7):2077–2083
https://doi.org/10.2337/dc12-1868
Published: 12 June 2013
View article titled, Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes
Open the PDF for Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

The Association Between Dietary Sodium Intake, ESRD, and All-Cause Mortality in Patients With Type 1 Diabetes

Merlin C. Thomas, MBCHB, John Moran, MD, Carol Forsblom, DMSC, Valma Harjutsalo, MD, Lena Thorn, MD, Aila Ahola, MD, Johan Wadén, MD, Nina Tolonen, MD, Markku Saraheimo, MS, Daniel Gordin, MSC, Per-Henrik Groop, MD, for the FinnDiane Study Group
Journal: Diabetes Care
Diabetes Care 2011;34(4):861–866
https://doi.org/10.2337/dc10-1722
Published: 21 March 2011
View article titled, The Association Between Dietary Sodium Intake, ESRD, and All-Cause Mortality in Patients With Type 1 Diabetes
Open the PDF for The Association Between Dietary Sodium Intake, ESRD, and All-Cause Mortality in Patients With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Pulse Pressure Predicts Incident Cardiovascular Disease but Not Diabetic Nephropathy in Patients With Type 1 Diabetes (The FinnDiane Study)

Daniel Gordin, MD, Johan Wadén, MD, Carol Forsblom, DMSC, Lena Thorn, MD, Milla Rosengård-Bärlund, MD, Nina Tolonen, MD, Markku Saraheimo, MD, Valma Harjutsalo, PHD, Per-Henrik Groop, MD, for the FinnDiane Study Group
Journal: Diabetes Care
Diabetes Care 2011;34(4):886–891
https://doi.org/10.2337/dc10-2013
Published: 21 March 2011
View article titled, Pulse Pressure Predicts Incident Cardiovascular Disease but Not Diabetic Nephropathy in Patients With Type 1 Diabetes (The FinnDiane Study)
Open the PDF for Pulse Pressure Predicts Incident Cardiovascular Disease but Not Diabetic Nephropathy in Patients With Type 1 Diabetes (The FinnDiane Study) in another window
Includes: Supplementary data
Journal Articles

Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes

Lena M. Thorn, MD, Carol Forsblom, DMSC, Johan Wadén, MD, Markku Saraheimo, MD, Nina Tolonen, MD, Kustaa Hietala, MD, Per-Henrik Groop, DMSC, for the Finnish Diabetic Nephropathy (FinnDiane) Study Group
Journal: Diabetes Care
Diabetes Care 2009;32(5):950–952
https://doi.org/10.2337/dc08-2022
Published: 05 February 2009
View article titled, Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes
Open the PDF for Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Effect of Parental Type 2 Diabetes on Offspring With Type 1 Diabetes

Lena M. Thorn, MD, Carol Forsblom, MD, DMSC, Johan Wadén, MD, Jenny Söderlund, MSC, Milla Rosengård-Bärlund, MD, Markku Saraheimo, MD, Outi Heikkilä, MD, Kustaa Hietala, MD, Kim Pettersson-Fernholm, MD, DMSC, Jorma Ilonen, MD, DMSC, Per-Henrik Groop, MD, DMSC, on behalf of the FinnDiane Study Group
Journal: Diabetes Care
Diabetes Care 2009;32(1):63–68
https://doi.org/10.2337/dc08-0472
Published: 01 January 2009
View article titled, Effect of Parental Type 2 Diabetes on Offspring With Type 1 Diabetes
Open the PDF for Effect of Parental Type 2 Diabetes on Offspring With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Serum Adiponectin and Progression of Diabetic Nephropathy in Patients With Type 1 Diabetes

Markku Saraheimo, MD, Carol Forsblom, MD, DMSC, Lena Thorn, MD, Johan Wadén, MD, Milla Rosengård-Bärlund, MD, Outi Heikkilä, MD, Kustaa Hietala, MD, Daniel Gordin, MD, Jan Frystyk, MD, DMSC, PHD, Allan Flyvbjerg, MD, DMSC, Per-Henrik Groop, MD, DMSC, on behalf of the FinnDiane Study Group
Journal: Diabetes Care
Diabetes Care 2008;31(6):1165–1169
https://doi.org/10.2337/dc07-2306
Published: 01 June 2008
View article titled, Serum Adiponectin and Progression of Diabetic Nephropathy in Patients With Type 1 Diabetes
Open the PDF for Serum Adiponectin and Progression of Diabetic Nephropathy in Patients With Type 1 Diabetes in another window
Journal Articles

Physical Activity and Diabetes Complications in Patients With Type 1 Diabetes: The Finnish Diabetic Nephropathy (FinnDiane) Study

Johan Wadén, MD, Carol Forsblom, DMSC, Lena M. Thorn, MD, Markku Saraheimo, MD, Milla Rosengård-Bärlund, MD, Outi Heikkilä, MD, Timo A. Lakka, MD, DMSC, Heikki Tikkanen, MD, DMSC, Per-Henrik Groop, MD, DMSC, on behalf of the FinnDiane Study Group
Journal: Diabetes Care
Diabetes Care 2008;31(2):230–232
https://doi.org/10.2337/dc07-1238
Published: 01 February 2008
View article titled, Physical Activity and Diabetes Complications in Patients With Type 1 Diabetes: <subtitle>The Finnish Diabetic Nephropathy (FinnDiane) Study</subtitle>
Open the PDF for Physical Activity and Diabetes Complications in Patients With Type 1 Diabetes: <subtitle>The Finnish Diabetic Nephropathy (FinnDiane) Study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Leisure-Time Physical Activity Is Associated With the Metabolic Syndrome in Type 1 Diabetes: Effect of the PPARγ Pro12Ala polymorphism: the FinnDiane Study

Johan Wadén, MD, Lena M. Thorn, MD, Carol Forsblom, MD, DMSC, Timo Lakka, MD, DMSC, Markku Saraheimo, MD, Milla Rosengård-Bärlund, MD, Outi Heikkilä, MD, Maija Wessman, PHD, Joni A. Turunen, MD, Maija Parkkonen, BSC, Heikki Tikkanen, MD, DMSC, Per-Henrik Groop, MD, DMSC, on behalf of the FinnDiane Study Group
Journal: Diabetes Care
Diabetes Care 2007;30(6):1618–1620
https://doi.org/10.2337/dc06-2467
Published: 01 June 2007
View article titled, Leisure-Time Physical Activity Is Associated With the Metabolic Syndrome in Type 1 Diabetes: <subtitle>Effect of the PPARγ Pro12Ala polymorphism: the FinnDiane Study</subtitle>
Open the PDF for Leisure-Time Physical Activity Is Associated With the Metabolic Syndrome in Type 1 Diabetes: <subtitle>Effect of the PPARγ Pro12Ala polymorphism: the FinnDiane Study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Metabolic Syndrome in Type 1 Diabetes: Association with diabetic nephropathy and glycemic control (the FinnDiane study)

Lena M. Thorn, MD, Carol Forsblom, MD, DMSC, Johan Fagerudd, MD, DMSC, Merlin C. Thomas, MD, PHD, Kim Pettersson-Fernholm, MD, DMSC, Markku Saraheimo, MD, Johan Wadén, MD, Mats Rönnback, MD, Milla Rosengård-Bärlund, MD, Clas-Göran af Björkesten, MD, Marja-Riitta Taskinen, MD, DMSC, Per-Henrik Groop, MD, DMSC, on behalf of the FinnDiane Study Group
Journal: Diabetes Care
Diabetes Care 2005;28(8):2019–2024
https://doi.org/10.2337/diacare.28.8.2019
Published: 01 August 2005
View article titled, Metabolic Syndrome in Type 1 Diabetes: <subtitle>Association with diabetic nephropathy and glycemic control (the FinnDiane study)</subtitle>
Open the PDF for Metabolic Syndrome in Type 1 Diabetes: <subtitle>Association with diabetic nephropathy and glycemic control (the FinnDiane study)</subtitle> in another window
Journal Articles

Serum Adiponectin Is Increased in Type 1 Diabetic Patients With Nephropathy

Markku Saraheimo, MD, Carol Forsblom, MD, DMSC, Johan Fagerudd, MD, DMSC, Anna-Maija Teppo, PHD, Kim Pettersson-Fernholm, MD, DMSC, Jan Frystyk, MD, DMSC, PHD, Allan Flyvbjerg, MD, DMSC, Per-Henrik Groop, MD, DMSC, on behalf of the FinnDiane Study Group
Journal: Diabetes Care
Diabetes Care 2005;28(6):1410–1414
https://doi.org/10.2337/diacare.28.6.1410
Published: 01 June 2005
View article titled, Serum Adiponectin Is Increased in Type 1 Diabetic Patients With Nephropathy
Open the PDF for Serum Adiponectin Is Increased in Type 1 Diabetic Patients With Nephropathy in another window